DK0391629T3 - Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider - Google Patents

Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider

Info

Publication number: DK0391629T3
Authority: DK; Denmark
Prior art keywords: phosphorylated; inhibition; mineral deposition; peptides; polyanionic peptides
Prior art date: 1989-04-07

Application number

DK90303465.0T

Other languages

English (en)

Inventor

Charles Steven Sikes

Original Assignee

Univ South Alabama

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-04-07

Filing date

1990-03-30

Publication date

1997-12-15

1989-04-07 Priority claimed from US07/334,456 external-priority patent/US5051401A/en

1990-03-30 Application filed by Univ South Alabama filed Critical Univ South Alabama

1997-12-15 Application granted granted Critical

1997-12-15 Publication of DK0391629T3 publication Critical patent/DK0391629T3/da

Links

230000008021 deposition Effects 0.000 title abstract 2
229910052500 inorganic mineral Inorganic materials 0.000 title abstract 2
239000011707 mineral Substances 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
230000005764 inhibitory process Effects 0.000 title 1
229940024606 amino acid Drugs 0.000 abstract 3
BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 abstract 2
235000001014 amino acid Nutrition 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 2
229950006137 dexfosfoserine Drugs 0.000 abstract 2
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 abstract 2
BEWZOYANBGCCRH-VKHMYHEASA-N (2s)-5-amino-5-oxo-2-(phosphonoamino)pentanoic acid Chemical compound NC(=O)CC[C@@H](C(O)=O)NP(O)(O)=O BEWZOYANBGCCRH-VKHMYHEASA-N 0.000 abstract 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
FXDNYOANAXWZHG-VKHMYHEASA-N O-phospho-L-homoserine Chemical compound OC(=O)[C@@H](N)CCOP(O)(O)=O FXDNYOANAXWZHG-VKHMYHEASA-N 0.000 abstract 1
FXDNYOANAXWZHG-UHFFFAOYSA-N O-phospho-L-homoserine Natural products OC(=O)C(N)CCOP(O)(O)=O FXDNYOANAXWZHG-UHFFFAOYSA-N 0.000 abstract 1
125000000129 anionic group Chemical group 0.000 abstract 1
229960001230 asparagine Drugs 0.000 abstract 1
235000009582 asparagine Nutrition 0.000 abstract 1
229940009098 aspartate Drugs 0.000 abstract 1
CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical group N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 abstract 1
229930195712 glutamate Natural products 0.000 abstract 1
229940049906 glutamate Drugs 0.000 abstract 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
229960002743 glutamine Drugs 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
LGZSREIUDDFVJE-REOHCLBHSA-N phospho-asparagine Chemical compound NC(=O)C[C@@H](C(O)=O)NP(O)(O)=O LGZSREIUDDFVJE-REOHCLBHSA-N 0.000 abstract 1
USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 abstract 1
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 abstract 1
-1 poly-amino acid compound Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Oral & Maxillofacial Surgery (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Birds (AREA)
Peptides Or Proteins (AREA)
Polyamides (AREA)
Cosmetics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Materials For Medical Uses (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK90303465.0T 1989-04-07 1990-03-30 Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider DK0391629T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/334,456 US5051401A (en)	1989-04-07	1989-04-07	Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
US33967289A	1989-04-18	1989-04-18

Publications (1)

Publication Number	Publication Date
DK0391629T3 true DK0391629T3 (da)	1997-12-15

Family

ID=26989201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK90303465.0T DK0391629T3 (da)	1989-04-07	1990-03-30	Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider

Country Status (8)

Country	Link
EP (1)	EP0391629B1 (da)
JP (1)	JP2716241B2 (da)
AT (1)	ATE153344T1 (da)
CA (1)	CA2014051A1 (da)
DE (1)	DE69030747T2 (da)
DK (1)	DK0391629T3 (da)
ES (1)	ES2103725T3 (da)
GR (1)	GR3024363T3 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0523776A3 (en) *	1991-07-17	1993-05-26	Unilever N.V.	Oral compositions containing a phosphopeptide
US5227154A (en) *	1991-08-22	1993-07-13	The University Of Melbourne	Phosphopeptides for the treatment of dental calculus
DE4217847A1 (de) *	1992-05-29	1993-12-02	Basf Ag	Verwendung von Kondensaten der Asparaginsäure als Belagsverhinderer bei der Eindampfung von Zuckersäften
US5286480A (en) *	1992-06-29	1994-02-15	The Procter & Gamble Company	Use of N-acetylated amino acid complexes in oral care compositions
US5500208A (en) *	1994-06-07	1996-03-19	The Procter & Gamble Company	Oral compositions comprising a novel tripeptide
US6004390A (en)	1997-04-14	1999-12-21	Dentsply Detrey Gmbh	Tooth surface treatment composition and methods
KR20030095501A (ko) *	2002-06-12	2003-12-24	김운중	이산화티탄이 함유된 조화(造花) 및 그 제조방법
US20090149673A1 (en) *	2007-12-05	2009-06-11	Semprus Biosciences Corp.	Synthetic non-fouling amino acids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE73668T1 (de) *	1983-12-22	1992-04-15	Univ Melbourne	Karieshemmung.
CA1315480C (en) *	1986-06-12	1993-03-30	Eric Charles Reynolds	Phosphopeptides

1990
- 1990-03-30 AT AT90303465T patent/ATE153344T1/de not_active IP Right Cessation
- 1990-03-30 DK DK90303465.0T patent/DK0391629T3/da active
- 1990-03-30 EP EP90303465A patent/EP0391629B1/en not_active Expired - Lifetime
- 1990-03-30 ES ES90303465T patent/ES2103725T3/es not_active Expired - Lifetime
- 1990-03-30 DE DE69030747T patent/DE69030747T2/de not_active Expired - Fee Related
- 1990-04-06 JP JP2091944A patent/JP2716241B2/ja not_active Expired - Lifetime
- 1990-04-06 CA CA002014051A patent/CA2014051A1/en not_active Abandoned
1997
- 1997-08-06 GR GR970402010T patent/GR3024363T3/el unknown

Also Published As

Publication number	Publication date
ATE153344T1 (de)	1997-06-15
ES2103725T3 (es)	1997-10-01
DE69030747D1 (de)	1997-06-26
EP0391629A1 (en)	1990-10-10
EP0391629B1 (en)	1997-05-21
GR3024363T3 (en)	1997-11-28
DE69030747T2 (de)	1998-01-22
JPH0368598A (ja)	1991-03-25
JP2716241B2 (ja)	1998-02-18
CA2014051A1 (en)	1990-10-07

Publication	Publication Date	Title
AU625704C (en)	2001-07-26	4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof, compositions and uses therefor and processes of preparation.
CA2011294A1 (en)	1990-09-03	Carbonylation catalyst system
DE3751652D1 (en)	1996-02-08	Phosphopeptide
EP0705794A3 (en)	1998-01-28	Method of inhibiting sulfate scale in aqueous systems
NO870876L (no)	1987-09-07	Fremgangsmte for fremstilling av kopolymerer, samt katalysatorpreparater for anvendelse ved fremgangsmten.
DE69821600D1 (de)	2004-03-18	Von hydroxysäuren abgeleitete monomere und daraus hergestellte polymere
KR970704864A (ko)	1997-09-06	세정제 조성물
DK0463072T3 (da)	1995-06-12	Hidtil ukendte insulinforbindelser
CA2022392A1 (en)	1991-06-16	4-phosphonomethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane n-oxide and water-soluble salts thereof
DK0391629T3 (da)	1997-12-15	Inhibering af mineralaflejring ved hjælp af phosphorylerede og beslægtede polyanioniske peptider
PH30218A (en)	1997-02-05	A process for inhibiting growth or proliferation of virus
ATE97118T1 (de)	1993-11-15	Kesselsteinverhuetung.
CA2022187A1 (en)	1991-06-16	N,n-bis-phosphonomethyl taurine n-oxide and water-soluble salts thereof
HU9402536D0 (en)	1994-10-28	Lactol derivatives, thfir production and use
CA2032303A1 (en)	1991-06-17	Inhibitors of retroviral proteases
AU7236187A (en)	1987-11-09	Indoloquinone compounds
DK0543845T3 (da)	1995-06-19	Fremgangsmåde til fremstilling af aminomethanphosphonsyre og aminomethyl-phosphinsyrer
DE69427148D1 (de)	2001-05-31	Verfahren zur Herstellung von 2,4,5-Tribrompyrrol-3-carbonitril
EP0679659A4 (en)	1996-05-22	Cathepsin-l-specific inhibitor polypeptide.
HU9502737D0 (en)	1995-11-28	Process for the preparation of condensed carbapeneme derivatives
HUT57234A (en)	1991-11-28	Process for synthesis of lh-rh analogues by applying temporary minimal protection
ATE179984T1 (de)	1999-05-15	Salze von aminoglykosiden
ATE88509T1 (de)	1993-05-15	Korrosionsinhibierung in waessrigen systemen.